- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Myeloid Hematological Malignancies
Total 18153 results
-
Baylor College of MedicineCenter for Cell and Gene Therapy, Baylor College of MedicineCompletedMyeloid Hematological MalignanciesUnited States
-
Charite University, Berlin, GermanyUniversity of LeipzigUnknownAcute Myeloid Leukemias | Advanced Hematological Malignancies | Indication for Allogeneic Stem Cell Transplantation | no HLA-identical Donor AvailableGermany
-
Hospices Civils de LyonUnknown
-
Memorial Sloan Kettering Cancer CenterCompletedLymphoma | Acute Myeloid Leukemia | Leukemia | Myelodysplastic Syndrome | Myeloma | Hematological MalignancyUnited States
-
Nanjing Chia-tai Tianqing PharmaceuticalRecruitingRelapsed/Refractory Acute Myeloid Leukemia (AML)China
-
The Affiliated People's Hospital of Ningbo UniversityUTC Therapeutics Inc.RecruitingLymphoma | Leukemia | Myeloma | Relapsed/Refractory Hematological MalignanciesChina
-
Centre Hospitalier Universitaire de NiceRecruiting
-
iCell Gene TherapeuticsiCar Bio TherapeuticsNot yet recruitingHigh Risk Hematologic Malignancies | Relapsed and/or Refractory Acute Myeloid LeukemiaChina
-
Ospedale Santa Croce-Carle CuneoUnknownAdvanced Haematological Malignancies | High Risk Haematological MalignanciesItaly
-
Catherine BollardJohns Hopkins University; Children's National Research InstituteRecruitingRelapsed/Refractory Hematopoietic Malignancies, Acute Myeloid Leukemia and MDSUnited States
-
Tel-Aviv Sourasky Medical CenterMeir Medical Center; Max Planck Institute for Infection BiologyUnknownPediatric Solid Malignancies | Pediatric Hematological MalignanciesIsrael
-
Gilead SciencesCalifornia Institute for Regenerative Medicine (CIRM)CompletedAcute Myeloid Leukemia | Myelodysplastic SyndromeUnited Kingdom
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.RecruitingRelapsed/Refractory Hematological MalignanciesChina
-
AdaptimmuneRecruitingSolid and Hematological MalignanciesUnited States, Spain, Canada, United Kingdom
-
Kite, A Gilead CompanyEnrolling by invitationSolid and Hematological MalignanciesUnited States, Netherlands, Japan, Australia, France, Israel, Germany, Canada, United Kingdom
-
AstraZenecaParexelCompletedSolid and Hematological MalignanciesGermany
-
Centre Hospitalier Universitaire de BesanconTerminatedHematological Malignancies BFrance
-
AdaptimmuneTerminatedSolid and Hematological MalignanciesUnited States, Canada
-
Erasca, Inc.WithdrawnAcute Myeloid LeukemiaUnited States
-
St. Jude Children's Research HospitalOhio State University; Arog Pharmaceuticals, Inc.CompletedAcute Myeloid LeukemiaUnited States
-
CASI Pharmaceuticals, Inc.CompletedRelapsed or Refractory Hematological MalignanciesCanada
-
Medical College of WisconsinCompletedMalignancies, HematologicUnited States
-
He HuangYake Biotechnology Ltd.RecruitingRelapsed and Refractory | Lymphoid Hematological MalignanciesChina
-
Constellation PharmaceuticalsCompletedSolid Tumor | Advanced Malignancies | Hematological MalignancySpain, United States, Georgia
-
Centre Hospitalier Universitaire de NīmesRecruitingLeukemia | Chronic Leukemia | Myelogenous Leukemia | BCR-ABL Positive Acute Myeloid LeukemiaFrance
-
Gilead SciencesTerminatedAcute Myeloid Leukemia | Hematologic MalignancyJapan
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Not yet recruitingAdvanced Solid Tumors and Hematological Malignancies
-
Institute of Hematology & Blood Diseases HospitalJuventas Cell Therapy Ltd.AvailableRelapsed and Refractory Hematological MalignanciesChina
-
Shandong UniversityJuventas Cell Therapy Ltd.UnknownRelapsed or Refractory Hematological MalignanciesChina
-
AstraZenecaParexelActive, not recruitingAdvanced Haematological MalignanciesSpain, United States, Canada, Korea, Republic of, Poland, Australia, France, United Kingdom, Ireland
-
Minsk Scientific-Practical Center for Surgery,...Belarusian State Medical UniversityCompletedHematological InfectionBelarus
-
University of California, DavisCompletedHematologic MalignanciesUnited States
-
AmgenCompletedLeukemia | Myeloid Leukemia | Cancer | Hematologic MalignanciesUnited States
-
Senti BiosciencesRecruitingAML/MDS | CD33 Expressing Hematological Malignancies | FLT3 Expressing Hematological MalignanciesUnited States, Australia
-
AmgenCompletedAnemia | Non-Myeloid Malignancies
-
St. Jude Children's Research HospitalRecruitingHematologic Malignancy | Myeloid MalignancyUnited States
-
Baylor College of MedicineCenter for Cell and Gene Therapy, Baylor College of MedicineWithdrawnLymphoid Hematological Malignancies | Umbilical Cord Blood Transplant
-
Institut de Recherches Internationales ServierRecruitingMyelodysplastic Syndromes | Relapsed or Refractory Acute Myeloid Leukemia (AML) | Untreated AML | Other IDH1-mutated Positive Hematologic MalignanciesUnited States, France
-
AmgenCompletedAnemia | Non-Myeloid Malignancies
-
St. Jude Children's Research HospitalCompletedAcute Myeloid Leukemia | Bone Marrow Transplantation | Hematologic MalignancyUnited States
-
AmgenCompletedAnemia | Non-Myeloid Malignancies
-
AvenCell Europe GmbHAllucent (NL) BVRecruitingAcute Myeloid Leukemia, in Relapse | Acute Myeloid Leukemia RefractoryGermany, Netherlands
-
PfizerCompletedAcute Myeloid LeukemiaJapan
-
Gilead SciencesCompletedMyeloid MalignanciesUnited States, Australia, United Kingdom
-
Southwest Hospital, ChinaUnknown
-
Cleave Biosciences, Inc.TerminatedLymphoid Hematological Malignancies | Relapsed and Refractory Multiple MyelomaCanada, United States
-
Centre Hospitalier Universitaire de Saint EtienneInstitut de Cancérologie de la LoireCompletedHematological Malignancies Treated With Intensive ChemotherapyFrance
-
AmgenCompletedCancer | Anemia | Non-Myeloid Malignancies
-
Sichuan UniversityRecruitingMyeloid MalignanciesChina